Terug
Dagbereik
€ 3,43
€ 3,68
52-Weeksbereik
€ 1,64
€ 5,63
Volume
11.794.990
50D / 200D Gem.
€ 3,20
/
€ 2,53
Vorige Slotkoers
€ 3,63
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,1 | 0,3 |
| P/B | 1,7 | 2,9 |
| ROE % | -55,5 | 3,7 |
| Net Margin % | -148,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 2,00
-44.8%
Forward WPA
-€ 0,50
Omzet Sch.
380 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,22
€ 0,18 – € 0,27
|
870 M | 2 |
| FY2029 |
€ 0,10
€ 0,08 – € 0,13
|
790 M | 4 |
| FY2028 |
€ 0,01
-€ 0,11 – € 0,19
|
740 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -336,24M
PEG of 0,17 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)60,60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-55,50%
ROIC-40,50%
Net Margin-148,38%
Op. Margin-153,08%
Veiligheid
Debt / Equity
0,07
Current Ratio3,20
Interest Coverage0,00
Waardering
P/E Ratio
-3,07
P/B Ratio1,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60,60% | Revenue Growth (3Y) | 1388,68% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 263,50M | Net Income (TTM) | -390,98M |
| ROE | -55,50% | ROA | -42,82% |
| Gross Margin | 97,23% | Operating Margin | -153,08% |
| Net Margin | -148,38% | Free Cash Flow (TTM) | -336,24M |
| ROIC | -40,50% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 3,20 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,07 | P/B Ratio | 1,72 |
| P/S Ratio | 4,56 | PEG Ratio | 0,17 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,20B | Enterprise Value | 1,09B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 263,50M | 164,07M | 1,19M | 0,0 | 0,0 |
| Net Income | -390,98M | -372,18M | -444,04M | -395,89M | -342,25M |
| EPS (Diluted) | -1,09 | -1,28 | -1,89 | -2,49 | -2,23 |
| Gross Profit | 256,22M | 40,08M | -9,57M | 0,0 | 0,0 |
| Operating Income | -403,36M | -395,28M | -460,56M | -398,88M | -342,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 913,17M | 910,43M | 780,35M | 663,98M | 777,33M |
| Total Liabilities | 214,59M | 200,02M | 195,74M | 164,34M | 155,67M |
| Shareholders' Equity | 698,58M | 710,41M | 584,61M | 499,64M | 621,66M |
| Total Debt | 48,44M | 58,26M | 75,86M | 85,45M | 71,53M |
| Cash & Equivalents | 163,08M | 115,69M | 114,89M | 231,73M | 78,23M |
| Current Assets | 442,69M | 457,02M | 307,85M | 479,12M | 507,96M |
| Current Liabilities | 138,36M | 122,34M | 110,31M | 91,49M | 89,20M |